Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,131,096    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,069,946      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 28 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-22 4 D $81.36 $1,063,782 D/D (13,075) 284,031 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-22 4/A D $81.36 $1,068,013 D/D (13,127) 283,979 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-22 4 D $88.05 $1,155,832 D/D (13,127) 323,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-20 4 D $73.05 $959,000 D/D (13,128) 297,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Business Officer   •       •      –    2012-10-23 5 GD $0.00 $0 D/D 13,545 135,901 0 -
BMRN Biomarin Pharmaceutical I... Chief Business Officer   •       •      –    2012-10-23 5 GA $0.00 $0 I/I 13,545 13,545 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-15 4 D $83.57 $1,245,862 D/D (14,908) 249,766 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-05-03 4 AS $16.70 $251,807 D/D (15,000) 17,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-05-03 4 OE $6.46 $96,900 D/D 15,000 32,695 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-12-17 4 OE $6.46 $96,900 D/D 15,000 22,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-12-17 4 AS $35.15 $532,934 D/D (15,000) 7,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-01-02 4 OE $6.46 $96,900 D/D 15,000 22,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-01-02 4 AS $35.28 $540,978 D/D (15,000) 7,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-03-09 4 OE $6.47 $97,050 D/D 15,000 129,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-03-09 4 S $34.46 $516,867 D/D (15,000) 114,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-08 4 OE $9.86 $147,900 D/D 15,000 128,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-08 4 AS $36.52 $547,800 D/D (15,000) 113,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-14 4 S $38.13 $571,893 D/D (15,000) 168,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-14 4 OE $9.86 $147,900 D/D 15,000 183,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-16 4 AS $38.47 $577,370 D/D (15,000) 168,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-16 4 OE $9.86 $147,900 D/D 15,000 183,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-14 4 S $70.17 $1,052,492 I/I (15,000) 20,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-14 4 OE $12.99 $194,850 I/I 15,000 35,609 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-09 4 OE $12.99 $194,850 I/I 15,000 57,279 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-15 4 OE $38.59 $578,850 D/D 15,000 279,674 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28  29   30   31   32   33   34      
  Page 28 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us